Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Screening Study for the Selection of Patients for Clinical Studies Targeting Tumor-specific Antigens

NCT05158621 is registered in ClinicalTrials.gov with Gritstone bio, Inc. as lead sponsor.

NCT NCT05158621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05158621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Screening Study for the Selection of Patients for Clinical Studies Targeting Tumor-specific Antigens
Lead sponsor
Gritstone bio, Inc.
Phase
Observational
Overall status
Completed
Start date
December 14, 2021
Completion date
August 15, 2022
Enrollment
22 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer, stage ii/iii colon cancer